Study to Evaluate the Efficacy, Safety, and Tolerability of BOS-589 in the Treatment of Patients With Diarrhea-predominant Irritable Bowel Syndrome (IBS-D)
Condition:   Diarrhea-predominant Irritable Bowel Syndrome Interventions:   Drug: BOS-589;   Drug: Placebo Sponsor:   Boston Pharmaceuticals Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 6, 2019 Category: Research Source Type: clinical trials

qQ-lab Daily-IBS for Irritable Bowel Syndrome
Condition:   Irritable Bowel Syndrome (IBS) Interventions:   Dietary Supplement: gQ-lab daily;   Dietary Supplement: Placebo Sponsor:   IlDong Pharmaceutical Co Ltd Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 27, 2019 Category: Research Source Type: clinical trials

Implementing a Low FODMAP Diet in Irritable Bowel Syndrome Patients
Condition:   IBS - Irritable Bowel Syndrome Interventions:   Other: Registered dietitian;   Other: On-line video program;   Other: Printed handout;   Other: Dietitian-led group Sponsor:   Mayo Clinic Enrolling by invitation (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 14, 2019 Category: Research Source Type: clinical trials

A Study of MD-7246 to Treat Abdominal Pain in Patients With Diarrhea-predominant Irritable Bowel Syndrome
Condition:   Irritable Bowel Syndrome With Diarrhea (IBS-D) Interventions:   Drug: MD-7246;   Drug: Placebo Sponsors:   Ironwood Pharmaceuticals, Inc.;   Allergan Sales, LLC Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 30, 2019 Category: Research Source Type: clinical trials

A Study of MD-7246 to Treat Abdominal Pain in Patients With Diarrhea-predominant Irritable Bowel Syndrome
Condition:   Irritable Bowel Syndrome With Diarrhea (IBS-D) Interventions:   Drug: MD-7246;   Drug: Placebo Sponsors:   Ironwood Pharmaceuticals, Inc.;   Allergan Sales, LLC Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 30, 2019 Category: Research Source Type: clinical trials